Medtronic and Qualcomm, Inc. announced a partnership to develop continuous glucose monitoring systems for patients with type 2 diabetes.
The companies initially plan on developing a single-use continuous glucose monitoring system for general practitioners. The agreement will combine Medtronic’s experience in diabetes management with Qualcomm’s experience in wireless technologies.
Medtronic currently has a MiniMed 530G system that includes an insulin pump and a glucose sensor. The system helps lower patients’ hemoglobin A1c levels and their risk of nerve, eye, and kidney problems. The FDA approved the MiniMed 530G system in September 2013.
Executive Editor
Tim Casey joined TriMed Media Group in 2015 as Executive Editor. For the previous four years, he worked as an editor and writer for HMP Communications, primarily focused on covering managed care issues and reporting from medical and health care conferences. He was also a staff reporter at the Sacramento Bee for more than four years covering professional, college and high school sports. He earned his undergraduate degree in psychology from the University of Notre Dame and his MBA degree from Georgetown University.